"dopesick" Breakthrough Pain(2021) ✮

Instead of acknowledging that the drug's time-release mechanism was failing, Purdue's marketing team told doctors that their patients were experiencing "breakthrough pain". Their proposed solution was not to switch medications, but to . This "individualizing of the dose" bypassed standard medical warnings that a patient might be developing a dangerous tolerance or addiction. Key Characters Caught in the Crisis

The episode highlights how this strategy devastated real lives through fictionalized avatars of the crisis: "Dopesick" Breakthrough Pain(2021)

Historically, the term "breakthrough pain" referred to a transitory flare of intense pain in patients already managed on a stable opioid regimen, typically those with cancer. However, in the series, Purdue Pharma executives, led by , weaponize the term to address a growing problem: OxyContin was not lasting the promised 12 hours for many patients. Key Characters Caught in the Crisis The episode